Probio Sphere (60 ct)
Probio Sphere (60 ct)

Probio Sphere (60 ct)

Regular price
Regular price
Sale price
Unit price
Sold out

Probiotics are naturally occurring friendly bacteria that are an integral part of a healthy digestive system. They exist primarily in the small and large intestine, enhancing health in several key ways. They help by assisting with food and nutrient assimilation, inhibiting harmful bacteria and by stimulating the immune system. Proper probiotic supplementation replaces intestinal tract organisms lost to antibiotic use, disease, poor diets, stress and other factors.

Common Problems with Probiotic Supplements

  • Strain identification and count is very difficult – proper technology is critical
  • Prevention of strain crossover
  • Strain integrity and stability
  • Very unstable to stomach acid
  • Poor handling by manufacturer and supplier is common
  • Moisture entering capsules negatively affects longevity of probiotic viability

Practitioners and savvy consumers alike are becoming increasingly aware of the importance of supplementing with probiotic bacteria. However, there continues to be confusion regarding the potency and efficacy of probiotic dietary supplements.

It’s All About Survival

Probiotic organisms must survive three major barriers in order to be beneficial for human health.

  • Barrier 1: Survival during the manufacturing process
  • Barrier 2: Survival on the shelf
  • Barrier 3: Survival through stomach acid

How? Probio Sphere is formulated to survive these barriers. We use technology that uses the most advanced patented delivery and shelf stability technology available to ensure maximum potency and viability. This is achieved using the latest BIO-tract Probiospheres® tableting technology designed to protect fragile probiotic organisms from harsh stomach acid and deliver the highest number of live organisms to the intestinal tract.

Why the sphere? The sphere shape has been shown to ensure maximum protection against stomach acid, resulting in the optimal delivery of viable organisms. The end result—higher potency, superior delivery, and minimal waste. Probio Sphere technology allows for a highly efficient, cost-effective way to introduce probiotics and enjoy their benefits, which include:

  • Immune defense at the intestinal and systemic level
  • Minimize the side effects of antibiotics
  • Minimize allergic responses
  • Prevention/alleviation of traveler’s diarrhea
  • Prevention/alleviation of diarrhea and constipation in infants, adults and elderly
  • Inhibit growth of pathogenic organisms: bacteria, yeast, parasites
  • Improve digestion of lactose
  • Alleviate inflammatory bowel disease/ulcerative colitis
  • Vitamin K synthesis
  • Alleviate atopic dermatitis


1. Lin CK, Tsai HC, Lin PP, Tsen HY, Tsai CC. Lactobacillus acidophilus LAP5 able to inhibit the Salmonella choleraesuis invasion to the human Caco-2 epithelial cell. Anaerobe. 2008 Nov;14(5):251-5. Epub 2008 Aug 22.

2. Betsi GI, Papadavid E, Falagas ME. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am J Clin Dermatol. 2008;9(2):93-103.

3. Prescott SL, Wickens K, Westcott L, Jung W, Currie H, Black PN, Stanley TV, Mitchell EA, Fitzharris P, Siebers R, Wu L, Crane J; Probiotic Study Group. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clin Exp Allergy. 2008 Oct;38(10):1606-14. Epub 2008 Jul 2.

4. Johnston BC, Supina AL, Ospina M, Vohra S. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD004827.

5. Toki S, Kagaya S, Shinohara M, Wakiguchi H, Matsumoto T, Takahata Y, Morimatsu F, Saito H, Matsumoto K. Lactobacillus rhamnosus GG and Lactobacillus casei suppress Escherichia coli-induced chemokine expression in intestinal epithelial cells. Int Arch Allergy Immunol. 2009;148(1):45-58. Epub 2008 Aug 21.

6. Amit-Romach E, Uni Z, Reifen R. Therapeutic potential of two probiotics in inflammatory bowel disease as observed in the trinitrobenzene sulfonic acid model of colitis. Dis Colon Rectum. 2008 Dec;51(12):1828-36. Epub 2008 Jul 17.